Realeve

Realeve is a medical device company dedicated to developing innovative solutions for autonomic disorders with an initial focus on cluster headaches treartment, but with the ultimate goal of pioneering work in Blood Brain Barrier permeability. This MRI-compatible neurostimulator device (FDA breakthrough) offers ondemand stimulation of the sphenopalatine ganglion (SPG), a key nerve structure involved in autonomic disorders by regulating blood brain barrier flow/permeability. The Pulsante System has been successfully implanted in over 700 patients in the US/Europe, with promising results, including a randomized controlled trial published in The Lancet.

www.Realeve.net